For patients with low-risk prostate cancer managed with active surveillance, obesity may increase risk of progression
the ONA take:
According to a new study published in the journal European Urology, researchers have found that obesity is linked with an increased risk of progression of low-risk prostate cancers in patients that are managed by active surveillance.
For the study, the researchers identified 565 men undergoing active surveillance for low-risk prostate cancer. The researchers found that during the median follow-up of 48 months, 168 men (30%) experienced pathologic progression and 172 men (30%) experienced therapeutic progression.
They did not find an association between obesity and risk of progression at the time of confirmatory biopsy, but beyond that, obesity was linked with an increased risk of pathologic progression (P = 0.007) and therapeutic progression (P = 0.007).
For every 5 unit increase in body mass index (BMI), the risk of pathologic progression increases (HR = 1.5, 95% CI: 1.1-2.1, P = 0.02). Similarly, the risk of therapeutic progression increases in the same manner (HR = 1.4, 95% CI: 1.0-1.9, P = 0.05).
Ultimately, the findings suggest that obesity is associated with a significantly elevated risk of prostate cancer progression after the confirmatory biopsy.
Obesity linked with increased risk of progression of low-risk prostate cancers in active surveillance.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
- Nonadherence to Posttreatment Imaging Follow-up Common Among Breast Cancer Survivors
- HIIT Improves Cardiorespiratory Fitness in Patients With Resectable NSCLC
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|